Associated Papers
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution.
Nguyen DD et al.
Nature, 2024
39385020 (PubMed )
Supplement: 41586_2024_7955_MOESM11_ESM.xlsx › Figure_3e
Ephrin-Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies.
Mekala S et al.
Journal of Cell Communication and Signaling, 2023
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
Leiserson MD et al.
Nature Genetics, 2015
25501392 (PubMed )
Supplement: NIHMS644198-supplement-3.xlsx › 20
Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms.
Lisabeth EM et al.
Biochemistry, 2012
Low frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma.
Bae HJ et al.
Neoplasma, 2009
Select a paper to view details